medicine grade meloxicam
Introduction
Name: high quality Meloxicam with BP2007 &EP6.0
MF: C14H13N3O4S2
Molecular Weight: 351.40
CAS: 71125-38-7
Standard: EP6/BP2007
Appearance: A pale yellow powder
Type: Antipyretic Analgesics and NSAIDs
Specification
Function
Older patients and patients with an increased risk of adverse reactions;
In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for 7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.
Patients with renal insufficiency:
Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.
Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine clearance greater than 25ml/minutes).
Patients with severe renal failure without dialysis, see [taboo].
Patients with hepatic insufficiency:
In patients with mild and moderate hepatic insufficiency no need to adjust the dose.
In patients with severe hepatic insufficiency, see [taboo].
Application
Used to treat symptoms of rheumatoid arthritis and painful osteoarthritis ( degenerative joint disease, bone and joint disease ) treatment.
Package
1kg/bag, 25kg/drum
